Skip to main content
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2025 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2025 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2024 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Skip to main content
Latest news
Our company
Careers
Investors
Media center
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Discover J&J
Discover J&J
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Event Details
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2025 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2025 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2024 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Johnson & Johnson 2023 Enterprise Business Review
Dec 5, 2023 10:00 AM ET
Webcast
(opens in new window)
Presentations & Other Resources
(opens in new window)
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com